Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637777 · ClinicalTrials.gov registry record
The Human Microbiome and IVF Outcomes
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 332
- Enrollment target
NCT03637777: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT03637777 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 332 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637777 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 332 participants
- Enrollment target
Study Summary
Patients and partners undergoing an autologous IVF cycle will be recruited to participate in this prospective observational study investigating the microbiome and its association with IVF pregnancy outcomes. During the the controlled ovarian hyperstimulation cycle as well as the frozen embryo transfer cycle, a number of specimens will be collected for next generation sequencing of 16S rRNA to evaluate the microbiome profile of the reproductive and gastrointestinal tracts. Data on pregnancy outcomes will be collected prospectively and evaluated to identify associations with the microbiome.
Primary Outcome
Delivery of a live infant
Interventions
- DIAGNOSTIC_TEST 16S rRNA gene sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2022-12-15 |
What the finished NCT03637777 record still lists
NCT03637777 is an observational study that tracks outcomes without assigning an intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 16S rRNA gene sequencing is the first listed.
NCT03637777 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03637777 about?
NCT03637777 is a clinical study titled "The Human Microbiome and IVF Outcomes". Patients and partners undergoing an autologous IVF cycle will be recruited to participate in this prospective observational study investigating the microbiome and its association with IVF pregnancy outcomes. During the the controlled ovarian hyperstimulation cycle as well as the frozen embryo transf...
What is the current status of trial NCT03637777?
This trial is currently completed. The enrollment target is 332 participants. The study started on 2018-08-13. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT03637777?
The interventions under investigation include: 16S rRNA gene sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03637777?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI